Company Overview of iNtRON Biotechnology, Inc.
iNtRON Biotechnology, Inc., a bio new drug company, develops, manufactures, and commercializes bio-active agents targeting infectious organisms. The company offers super bacteria drugs, such as Sal 200 and NPA 200; cancer treating drug delivery media; heme-iron supplements, antibiotic alternative products for animals; nucleic acid tests, and various lab reagents and kits. It also focuses on providing novel products for new flu, VRE super bacteria, food poisoning, Al, e.t.c. iNtRON Biotechnology, Inc. was founded in 1999 and is headquartered in Seongnam, South Korea.
#701-704, 505, 903 JungAng Induspia
Seongnam, 461 804
Founded in 1999
82 3 1739 5678
82 3 1739 7246
Key Executives for iNtRON Biotechnology, Inc.
iNtRON Biotechnology, Inc. does not have any Key Executives recorded.
iNtRON Biotechnology, Inc. Key Developments
Similar Private Companies By Industry
|Korea Research Institute Of Bioscience And Biotechnology||Asia|
|Green Cross Plasma Derivatives Company||Asia|
Recent Private Companies Transactions
July 1, 2014
June 17, 2014
May 16, 2014
To contact iNtRON Biotechnology, Inc., please visit www.intron.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.